|
(ÁÖ)Æ÷ÀÎÆ®´Ð½º |
¹æ»ç¼±¾ÈÀü°ü¸®ÀÚ(RG)¸ðÁý
¼¿ï ±¸·Î±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
½ÅÀÔ |
ä¿ë½Ã |
04.21 |
|
|
(ÁÖ)¿ìÁø»óÇà |
ÀÇ·á±â±âº´¿ø¿µ¾÷, ±â±¸¿µ¾÷, °Å·¡¼± °³¹ß °ü¸® ½ÅÀÔ»ç¿ø¸ð
¼¿ï ¼ÛÆı¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
½ÅÀÔ |
ä¿ë½Ã |
03.19 |
|
|
PSI CRO Korea |
[PSI CRO Korea] CRA I/II
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
05.04 |
|
|
PharmaNet |
[Global CRO PharmaNet] °æ·Â CRA ±¸ÀÎ
¼¿ï °³²±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
03.30 |
|
|
¸Þµð¿þÀÌ |
¿µ¾÷Áö¿ª´ã´çÀÚ¸¦ ¸ð½Ê´Ï´Ù.
¼¿ï ÀüÁö¿ª, ÀÎõ ÀüÁö¿ª | ´ëÇÐ(2~3³â) ÀçÇÐ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
1³â¡è |
ä¿ë½Ã |
08.11 |
|
|
(ÁÖ)¼¼Á¾¾¾¾Ë¿À |
¼¼Á¾CRO - RA (Regulatory Affairs) ½ÅÀÔ ¹× °æ·ÂÀÚ ¸ðÁý
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
1³â¡è |
ä¿ë½Ã |
07.23 |
|
|
°³²Â÷º´¿ø |
°³²Â÷º´¿ø ¾ß°£¾à»ç Ãʺù ¾È³»
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
1³â¡è |
ä¿ë½Ã |
05.11 |
|
|
¢ß¿ÀÅ亹ÄÚ¸®¾ÆÇコÄɾî |
¢ß¿ÀÅ亹ÄÚ¸®¾ÆÇコÄɾî - °í°´ÀüÈ»ó´ã ¸®¼Ä¡ (TM À¯°æÇè
¼¿ï °³²±¸ | Çз¹«°ü |
¸¶ÄÉÆÃ/±âȹ/±³À° |
1³â¡è |
ä¿ë½Ã |
03.31 |
|
|
PSI CRO Korea |
[PSI CRO Korea] ä¿ë Á¤º¸
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
08.31 |
|
|
(ÁÖ)¾¾¿£¾Ë¸®¼Ä¡ |
¾¾¿£¾Ë¸®¼Ä¡ °³², ºÎ»ê [°æ·Â] CRA ä¿ë
¼¿ï °³²±¸, ºÎ»ê ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
08.06 |
|
|
¿¡ÀÌÇÁ·ÎÁ¨Æĸ¶(ÁÖ) |
¼¿ï°æ±âÁö¿ªMRä¿ëÇÕ´Ï´Ù
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
1³â¡è |
ä¿ë½Ã |
10.01 |
|
|
¿Ã¸®ºêÀ¯´Ï¿Â |
º¸Ã»±â ÀÇ·á±â±â ¿µ¾÷»ó´ã
¼¿ï ÀüÁö¿ª | ´ëÇÐ(2~3³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
1³â¡è |
»ó½Ãä¿ë |
07.19 |
|
|
ºñ¿À¸Þ¸®À¸ ÄÚ¸®¾Æ |
¢ßºñ¿À¸Þ¸®À¸ÄÚ¸®¾Æ ¿Ü±¹°è ü¿Ü Áø´Ü Þä, ÇмúÁ÷¿ø ä¿ë(°æ
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
1³â¡è |
ä¿ë½Ã |
03.26 |
|
|
PSI CRO Korea |
[PSI CRO Korea] CRA I/II
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
03.19 |
|
|
PSI CRO Korea |
[PSI CRO Korea] CTA I/II, Sr.CTA
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
CTA/CRC |
1³â¡è |
ä¿ë½Ã |
07.21 |
|